Oyo operator Oravel Stays Ltd is refiling the draft papers for its IPO by February, while Sun Pharmaceutical Industries is acquiring Concert Pharmaceuticals for $576 million in equity value.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
